Integra LifeSciences Holding Corp.

Development, manufacture, and marketing of medical devices for use in a variety of applications including neuro-trauma, neurosurgery, plastic and reconstructive surgery, soft tissue repair.

Integra LifeSciences Holdings Corporation is a diversified medical technology company but has also entered the tissue repair market. The company is traded at the NASDAQ stock exchange under the symbol IART. Integra has its corporate headquarters in Plainsboro, New Jersey, and manufacturing and research facilities throughout the world.

Stuart M. Essig, President, Director & CEO
Gerard S. Carlozzi, Executive VP & COO
John B. Henneman III, Executive VP, Acting CFO, Chief Administrative Officer and Secretary
Deborah A. Leonetti, Chief Marketing Officer

Richard E. Caruso Ph.D., Chairman
Thomas J. Baltimore, Jr.
Keith Bradley Ph.D.
Stuart M. Essig
Neal Moszkowski
Christian S. Schade
James M. Sullivan
Anne M. VanLent

311 Enterprise Drive Plainsboro
New Jersey 08536
USA
Phone: +1-609-275-0500
Fax: +1-609-275-3684

Apart from surgical instrument product lines (monitoring and drainage systems, surgical instruments, and fixation systems), the company is developing innovative tissue repair products. This includes the INTEGRA® Dermal Regeneration Template (regenerates dermis and repairs skin defects), dental surgery products such as BioMend® and BioMend® Extend Absorbable Collagen Membrane (used in guided tissue regeneration on periodontal surgery) or CollaCote®, CollaTape®, CollaPlug® (used to control bleeding in dental surgery); bone regeneration products include an absorbable collagen sponge for use with bone morphogenetic protein (rhBMP-2) or tyrosine polycarbonates for fixation devices such as absorbable screws, plates, pins, wedges and nails; and articular cartilage regeneration.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.